MHRA Authorises Rilzabrutinib for Adult ITP

The MHRA has authorised rilzabrutinib for adults with ITP where prior therapies have failed, based on phase 3 data showing durable platelet response.
Medscape News UK

Source link : https://www.medscape.com/viewarticle/mhra-authorises-rilzabrutinib-adult-itp-2026a1000ibk?src=rss

Author :

Publish date : 2026-06-02 17:43:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

MHRA Authorises Rilzabrutinib for Adult ITP

Volixibat Soothed the Itch in Primary Sclerosing Cholangitis

Docs Should Compete for Patient Dollars, Not Political Influence, Economist Says

Related Posts

First Clear Win for BTK Inhibitors in Relapsing MS

Health Groups Unhappy With Medicaid Work Requirement Interim Rule

Adding Immunotherapy-Based Combo Boosts PFS in Unresectable Liver Cancer

Protein Won’t Solve Our Nutrition Problem

Ultra-Low-Dose Immunotherapy May Benefit Cancer Patients in Low-Resource Countries

Ebola Webinar June 4: Former USAID Official Discusses Flawed U.S. Response

First Clear Win for BTK Inhibitors in Relapsing MS

Health Groups Unhappy With Medicaid Work Requirement Interim Rule

Adding Immunotherapy-Based Combo Boosts PFS in Unresectable Liver Cancer

Protein Won’t Solve Our Nutrition Problem

Ultra-Low-Dose Immunotherapy May Benefit Cancer Patients in Low-Resource Countries

Ebola Webinar June 4: Former USAID Official Discusses Flawed U.S. Response

Visceral Fat Over Weight Loss; BP Control Incentive Backfires; PVCs Not Benign

How the Brain Works at Night; An Unusual ARIA Case; Smartwatch Detects Seizures

Categories

Archives